Lhasa Limited

And that's a wrap on the last major conference for 2024! We had a great time at ACT 2024 in Austin, hosting a full-house for our session on setting limits for nitrosamines and other impurity classes using an in silico approach, including our read-across solution Acrostic 💻 Want to catch up on the key highlights? Our latest blog covers the standout sessions, our team's key takeaways, and current trends in the toxicology space! 📖 Read the full Lhasa re-cap here: https://buff.ly/4fPO66z #Toxicology #Nitrosamines #ACT2024 #Innovation #InSilico 

Join our webinar in Spanish, where we will discuss API safety through effective management of impurities and degradants under ICH M7! 💊 📅Thursday 28th November 🕙 10:00 - 12:00 COT / 12:00 - 14:00 ART / 16:00 - 18:00 CEST 🗣️ Spanish Register here: https://buff.ly/3Umwgzn ----------------------------- Únete a nuestro webinar en español, donde discutiremos la seguridad de APIs a través de una gestión efectiva de impurezas y degradantes bajo ICH M7! 💊 📅 Jueves 28 de Noviembre 🕙 10:00 - 12:00 COT / 12:00 - 14:00 ART / 16:00 - 18:00 CEST 🗣️ Español Registrate aquí: https://buff.ly/3Umwgzn ¡Te esperamos! #Webinar #Impurezas #ICHM7 Mariana Mendez, Maria Celeste del Fueyo, PhD, Lucía Toscano Bayona

Find out more and register: https://buff.ly/3A1ndwU We are delighted to be on the programme at the 10th Winter Process Chemistry Conference. Lhasa Principal Scientist Michael Burns will be presenting ‘Reactivities of N-nitrosamines against Common Reagents and Reaction Conditions’. The 10th Winter Process Conference will showcase presentations from International Chemists covering all aspects of Process Development. The speakers will discuss the latest issues in synthetic route design, development and optimisation, reactor design, work up and purification, crystallisation, process engineering, hazard studies and quality and regulatory issues. #MutagenicImpurities #Mirabilis #Nitrosamines

Last chance to register happening TOMORROW https://buff.ly/3AmGuJs Learn how to develop control strategies in line with ICH M7 guidelines without expensive and time-consuming analytical testing. This webinar will show you how you can assess carryover risk for potentially mutagenic impurities (including nitrosamines) in your drug development workflow. The webinar will include the follow presentations: ☑️ Andrew Teasdale - ‘Industry perspective: Controlling potentially mutagenic impurities – Using calculations to support purge arguments under ICH M7’ ☑️ Emma Pye - ‘Purge Factors as part of M7 Assessment of mutagenic impurity risk – Using #Mirabilis to assist in control strategies.’ and conclude with a live Q&A #Pharma #Nitrosamines #ICHM7 #MutagenicImpurities

👉 Learn more about our people: https://buff.ly/3YHAenI Read about Manya's Lhasa journey and the integral role collaboration plays in it: "After completing my Master's in Chemistry from the University of Glasgow, I joined Lhasa as an Application Scientist in Feb 2023. As an Application Scientist, I engage and collaborate with our members by giving them trainings and gathering feedback. This role allows me to work with different members and learn new things from them! As part of my role, I work as across multiple solution teams, which helps me to enhance my skills, expand my knowledge, and contribute to my personal development". #LifeAtLhasa #Culture #Values #Collaboration #MeetTheTeam

Find out more and register to attend the online conference https://buff.ly/4fcvjSp We are delighted to be on the programme at the 4th Annual Genotoxic Impurities Summit. Lhasa Principal Scientist Michael Burns will be presenting ‘Reactivities of N-nitrosamines against Common Reagents and Reaction Conditions’. This online meeting, organized in collaboration with industry professionals, aims to showcase and discuss different perspectives on addressing the challenges caused by mutagenic impurities. #MutagenicImpurities #ICHM7 #ICHQ3D #Mirabilis #Nitrosamines

Curious about #LifeAtLhasa? We believe our people are the heart of everything we do, which is why we’re thrilled to share our new video. Join our team from across the globe as they offer a glimpse into what makes Lhasa not just a workplace, but a community. 🎥 Watch the #video below. Read our blog post for more insights: https://buff.ly/4hYSLV9 #culture #values

Day two at American College of Toxicology (ACT) 2024 - we’re ready for you! Brilliant kick off to the conference yesterday, catching up with members and meeting new faces to discuss our in silico solutions 💡 If you’re attending, Lina Din and Amber Carr are here until 4:30 at Booth 313 - swing by and say hello! Plus, at midday we’ll be hosting our exhibitor hosted session on setting limits for nitrosamines and other impurity classes using in silico solutions, including read-across ➡️ Room 201 #ACT #Toxicology #InSilico

👉 ¿Hiciste alguna vez un análisis de riesgo mutagénico? 👈 La guía ICH M7 nos dice que para clasificar las impurezas podemos usar predicciones computacionales, siempre y cuando se apliquen dos metodologías QSAR complementarias. En Lhasa Limited desarrollamos #DerekNexus y #SarahNexus, que en línea con los requerimientos de la ICH M7 te permite que te conviertas en experto. 😎 🤩 ¿Te interesaría verlas en acción? 🤩 🗓 Te esperamos el 28 de Noviembre, 12 hs ART para nuestro webinar:  “Garantizando la seguridad de un API: estrategias para el manejo de impurezas y degradantes bajo ICH M7” 🌐 Online 🗣En español ✨ GRATUITO 🎉 sin cupo 🌎 Además, temenos el placer de contar con la presencia de Mariana Mendez, gerente de desarrollo bioanalítico de Baliarda, Argentina que nos va a contar una aplicación real y concreta de las herramientas. 🌎 ¡No te lo pierdas! #analisis #riesgo #ichm7 #industria #farmaceutica #impurezas #mutagenicas

I am in Austin, Texas for ACT at Booth #313 until Tuesday 19th of November, if you're attending come say hi and chat to myself, Charles (Charlie) Modlin, Ph.D. or Amber Carr to learn more about our in silico solutions. I look forward to meeting with you!